- Grants since 2016
- 279
- Awarded, last 5 years (where amounts are published)
- —
- Funded works, last 5 years
- 1 976
- Funded works, all time
- 5 201
Grants
2025 · research · PCF Young Investigator Award
Harnessing PARP-Targeting Radiotheranostics to Advance Treatment Strategies in Prostate Cancer
Chung Ying (Kathy) Chan · Institute of Cancer Research
2025 · research · PCF Challenge Award
Multifactorial Antigen-Presenting Gamma-Delta T cells Targeting Cancer and Viral Antigens for the Treatment of mCRPC
Saul Priceman · University of Southern California
2025 · research · PCF Challenge Award
Testing Deep Learning Algorithms for Prognostication and Prediction in Prostate Cancer: A Clinical Validation Study
Tamara Lotan · Johns Hopkins University
2025 · research · PCF Challenge Award
Selective Proximity Targeting of AR and p300/CBP as a Therapeutic Strategy in Prostate Cancer
Arul Chinnaiyan · University of Michigan
2025 · research · PCF Challenge Award
Harnessing Extracellular Vesicle and Cell-Free RNA Transcriptomics to Identify Novel Targets in Lethal Stem Cell-Like mCRPC
Oliver Sartor · Tulane University
2025 · research · PCF Young Investigator Award
Defining Evolution of Prostate Cancer Metastasis Under Therapeutic Pressure Using Recordable Barcode
Lise Brault · Weill Cornell Medicine
2025 · research · PCF Challenge Award
Theranostic Targeting of a Tumor-Specific Cleaved CDCP1 Epitope in Prostate Cancer
Jonathan Chou · University of California, San Francisco
2025 · research · PCF Challenge Award
Targeting AR by Proximity Induced Epigenetic Silencing (PIES) to Overcome Castration Resistance
Steven Balk · Mount Sinai Hospital
2025 · research · PCF Challenge Award
Elucidating New Molecular Targets and Defining the Androgen Spatial Heterogeneity in Lethal Prostate Cancer
Nima Sharifi · University of Miami
2025 · research · PCF Challenge Award
Detecting Molecular and Histopathological Correlates of Whole Genome Duplication in High-Risk Prostate Cancer
Ian Mills · University of Washington
2025 · research · PCF Young Investigator Award
Health Literacy in Advanced Prostate Cancer Care: Developing Evidence-Based Interventions to Support Patients with Low Health Literacy
Bashir Al Hussein Al Awamlh · Weill Cornell Medicine
2025 · research · PCF Challenge Award
Predicting Off-Target Resistance to Androgen Receptor Signaling Inhibitors from Histology Slides using Foundation Models
Ekta Khurana · Memorial Sloan Kettering Cancer Center
2025 · research · PCF Young Investigator Award
Integrated Profiling of Spatial and Circulating Biomarkers to Optimize Precision Therapy in Advanced Prostate Cancer
Jacob Berchuck · Emory University
2025 · research · PCF Young Investigator Award
Developing First-In-Class AR/AR-V7 Molecular Glue Degrader To Revolutionize Prostate Cancer Therapeutics
Cheukman Cherie Au · Weill Cornell Medicine
2025 · research · PCF Young Investigator Award
Targeting Sox2 Regulatory Networks that Drive Distal-Proximal Lineage Plasticity in Prostate Cancer Progression
Jinqiu Lu · Columbia University Irving Medical Center
2025 · research · PCF Young Investigator Award
Rationally Designed Therapeutic Strategies for Effective targeting of DNA-Hypomethylated Prostate Cancers
Pallabi Mustafi · Fred Hutch Cancer Center
2025 · research · PCF Young Investigator Award
Roles, Regulations, and Therapeutic Potential of the Lysine Acetoacetylome in Prostate Cancer
Zhipeng Wang · University of Miami
2025 · research · PCF Young Investigator Award
The Impact of Tandem Repeats on the Evolution of Prostate Cancer: From Germline Features to Predicting Clinical Behavior
Gianmarco Leone · University College London
2025 · research · PCF Young Investigator Award
Decoding the Molecular Landscape of BRCA1/2-Associated Prostate Cancer: Insights from Single-Cell and Spatial Transcriptomics to Uncover Tumor Heterogeneity and Therapeutic Targets
Nabamita Boruah · University of Pennsylvania
2025 · research · PCF Young Investigator Award
Evaluating the Impact of BRCA2 Immune Cell Heterozygosity on Therapeutic Approaches for Advanced Prostate Cancer
Anne Fassl · Goethe University Frankfurt
2025 · research · PCF Young Investigator Award
Assessing the Impact of GLP-1 Receptor Agonists and SGLT2 Inhibitors on Advanced Prostate Cancer Risk and Outcomes
Kevin Kensler · Weill Cornell Medicine
2025 · research · PCF Challenge Award
PARP Inhibition with SABR for High-Risk Mutation Oligometastatic Castration-Sensitive Prostate Cancer
Matthew Deek · University of Wisconsin System
2025 · research · PCF Young Investigator Award
Mechanisms of RB1-Dependent Epigenomic Regulation of Prostate Cancer Neuroendocrine Plasticity
Rodrigo Romero · The University of Texas MD Anderson Cancer Center
2025 · research · PCF Young Investigator Award
Metabolic Synthetic Lethality in SPOP-Mutant Prostate Cancer
Joanina Gicobi · Mayo Clinic
2025 · research · PCF Young Investigator Award
Targeted Delivery of NSD2 Inhibitors Reverse Epigenetic Resistance and Improve Prostate Cancer Immunotherapy
Blaise Kimmel · The Ohio State University
2025 · research · PCF Young Investigator Award
Investigating a Novel Immunotherapeutic Targeting CEACAM5 in Androgen Indifferent Prostate Cancer
Charles Nguyen · City of Hope
2025 · research · PCF Young Investigator Award
Lipid Metabolism as a Key Regulator of Prostate Cancer State Transitions and Therapy Resistance
Silvia Rodrigues · Weill Cornell Medicine
2025 · research · PCF Challenge Award
Targeting Extrachromosomal DNA in Prostate Cancer: A Novel Approach to Overcome Treatment Resistance
Rana Mckay · University of California San Diego
2025 · research · PCF Young Investigator Award
NLGN1-NRXN1α as a Predictive Spatial Biomarker for Prostate Cancer Progression and Treatment
Sebnem Ece Eksi · Oregon Health & Science University
2025 · research · PCF TACTICAL Award
Unravelling Drivers of Treatment Resistance to PSMA-Lu in Patients with Metastatic Hormone Sensitive Prostate Cancer (mHSPC) and Identification of New Therapeutic Targets to Overcome It
Nick James · The Christie Hospital
2025 · research · PCF Young Investigator Award
Investigating Mechanistic Role of RAD21/Cohesin in Advanced Prostate Cancers
Allen (Xiaofeng) Su · Center For Prostate Disease Research (cpdr)
2025 · research · PCF Young Investigator Award
Real-world Evaluation of Advanced, Late-stage Metastatic Prostate Cancer (REALM)
Pawel Rajwa · University College London
2025 · research · PCF Young Investigator Award
Leveraging Lifestyle Medicine to Improve Survivorship for Vulnerable Metastatic Prostate Cancer Survivors at a Large Safety-Net Hospital
Nnenaya Mmonu · New York University
2025 · research · PCF Young Investigator Award
Loss of the Y Chromosome as a Driver of Tumor Aggressiveness and Novel Biomarker for Immunotherapeutic Response in Prostate Cancer
Timothy Gauntner · The Ohio State University
2025 · research · PCF Young Investigator Award
MBD4-Driven AR Reprogramming and Luminal Lineage Specification in Prostate Cancer
Xuanrong Chen · Weill Cornell Medicine
2025 · research · PCF Young Investigator Award
Developing a Dual PROTAC-type Degrader Platform for Simultaneous AR and GR Degradation Against Lethal Prostate Cancer
Su Deng · Yale University
2025 · research · PCF Young Investigator Award
Discern the Impact of Circadian Cryptochrome 1 (CRY1) on Metabolic Rewiring in Prostate Cancer
Arwa Fallatah · Hjf – Henry Jackson Foundation For The Advancement Of Military Medicine / Uniformed Services University
2025 · research · PCF Young Investigator Award
177Lu-PSMA-617 in PSMA PET(+) Biochemically Recurrent Prostate Cancer
Melissa Abel · National Institutes of Health
2025 · research · PCF Young Investigator Award
Defining Tumor-Immune System Interactions in BRCA2 Deficient Prostate Cancer to Identify Therapeutic Vulnerabilities
Kimberly Rickman · University of California, San Francisco
2025 · research · PCF Young Investigator Award
Epigenetic Priming to Enhance PSMA Expression and Response to PSMA Targeted Therapy in PSMA-Low Metastatic Castration Resistant Prostate Cancer
Ruben Raychaudhuri · Fred Hutch Cancer Center